PWAM
VKTX icon

Park West Asset Management’s Viking Therapeutics VKTX Stock Holding History

Park West Asset Management’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,000
Closed -$4.92M – 51
2024
Q1 		$4.92M Buy
+60,000
New +$2.67M 0.35% 37
2022
Q3 		– Sell
-2,468,587
Closed -$7.13M – 68
2022
Q2 		$7.13M Hold
2,468,587
– – 0.4% 39
2022
Q1 		$7.41M Buy
2,468,587
+850,000
+53% +$3.05M 0.26% 55
2021
Q4 		$7.45M Sell
1,618,587
-50,000
-3% -$280K 0.15% 74
2021
Q3 		$10.5M Hold
1,668,587
– – 0.25% 72
2021
Q2 		$9.99M Buy
1,668,587
+70,600
+4% +$419K 0.28% 81
2021
Q1 		$10.1M Buy
1,597,987
+106,922
+7% +$752K 0.31% 79
2020
Q4 		$8.39M Buy
1,491,065
+33,558
+2% +$203K 0.17% 86
2020
Q3 		$8.48M Hold
1,457,507
– – 0.33% 68
2020
Q2 		$10.5M Sell
1,457,507
-140,000
-9% -$930K 0.52% 49
2020
Q1 		$7.48M Buy
1,597,507
+52,432
+3% +$322K 0.51% 47
2019
Q4 		$12.4M Sell
1,545,075
-202,432
-12% -$1.48M 0.52% 49
2019
Q3 		$12M Hold
1,747,507
– – 0.59% 44
2019
Q2 		$14.5M Buy
1,747,507
+175,000
+11% +$1.5M 0.6% 47
2019
Q1 		$15.6M Sell
1,572,507
-100,000
-6% -$837K 0.69% 41
2018
Q4 		$12.8M Buy
1,672,507
+403,400
+32% +$4.82M 0.63% 48
2018
Q3 		$22.1M Buy
1,269,107
+855,000
+206% +$10.2M 0.81% 40
2018
Q2 		$3.93M Sell
414,107
-85,893
-17% -$571K 0.15% 92
2018
Q1 		$2.19M Sell
500,000
-100,000
-17% -$553K 0.1% 81
2017
Q4 		$2.44M Buy
600,000
+400,000
+200% +$1.16M 0.11% 77
2017
Q3 		$382K Hold
200,000
– – 0.02% 69
2017
Q2 		$216K Buy
+200,000
New +$254K 0.01% 70

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Park West Asset Management's VKTX Position: Q2 2024 in Review

Park West Asset Management sold out of Viking Therapeutics (VKTX) in Q2 2024, closing a stake of 60,000 shares — an estimated $4.92M sold.

Park West Asset Management first reported a position in VKTX in Q2 2017 and held it in 22 quarters. The position peaked at $22.1M in Q3 2018. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

  • Park West Asset Management reported no remaining Viking Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Park West Asset Management sold 60,000 Viking Therapeutics shares in Q2 2024, an estimated $4.92M.
  • Park West Asset Management first reported a position in Viking Therapeutics in Q2 2017 and held it in 22 quarters.
  • Park West Asset Management's Viking Therapeutics position peaked at $22.1M in Q3 2018.
  • 387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on Park West Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.